NCT06781008

Brief Summary

The purpose of the SWEtick project is to increase the knowledge of the various clinical presentations of emerging tick-borne diseases (eTBD), to assess their importance for human health, to develop and validate laboratory methods for diagnosis of eTBD, and to develop recommendations for knowledge-driven management of patients with suspected eTBD within the Swedish healthcare system.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
116mo left

Started Sep 2023

Longer than P75 for all trials

Geographic Reach
1 country

12 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Sep 2023Dec 2035

Study Start

First participant enrolled

September 1, 2023

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

January 8, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 17, 2025

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2030

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2035

Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

7.3 years

First QC Date

January 8, 2025

Last Update Submit

March 3, 2026

Conditions

Keywords

ClinicalProspectiveMulticenterObservationalLongitudinalCohort

Outcome Measures

Primary Outcomes (2)

  • EuroQoL-5 Dimension Questionnaire (EQ-5D)

    Difference in EQ-5D Health index between study inclusion and at the 6 month-follow-up

    6 months

  • Visual Analogue Scale for Health (VAS)

    Difference between the VAS units at study inclusion and at 6 month-follow-up.

    6 months

Study Arms (5)

TBD

Patients with confirmed tick-borne disease

Non-TBD

Patients investigated for suspected tick-borne disease but diagnosed with another condition (tick-borne disease excluded)

Control group CNS

Patients obtaining spinal anasthesia in conjunction with knee or hip replacement surgery due to arthrosis

Control group arthritis

Patients with autoinflammatory joint disease

Control group healthy

Blood donors

Eligibility Criteria

Age1 Year+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

1. Medical history: tick exposure, tick bite, splenectomy, immunosuppressive treatment (e.g. anti-CD20 or other biological/immunomodulatory drugs, cortisone corresponding to \>10 mg prednisolone/day, chemotherapy, hematologic malignancy, other malignancy, rheumatologic disease) 2. Symptoms/clinical signs: fever after tick bite, relapsing fever of unknown origin, skin rashes (single/multiple erythema migrans, lymphocytoma, acrodermatitis chronica atrophicans or other), venous thrombosis, repeated thrombophlebitis, meningitis, encephalitis, myelitis, cranial nerve palsy, radiculitis, peripheral nerve involvment, mono-/oligoarthritis, carditis, ocular or otogenic disturbances of uncertain origin where medical history includes recent tick bite. 3. Biochemical findings in combination with factors under a) and b): leukopenia, thrombocytopenia, anemia, elevated liver enzymes, slightly elevated erythrocyte sedimentation rate and/or C-reactive protein, pleocytosis in CSF or synovial fluid.

You may qualify if:

  • Clinical suspicion of tick-borne disease (physician's assessment based on medical history, symptoms, clinical findings and sometimes laboratory results)

You may not qualify if:

  • Incapacitated to understand the study information and make decisions (adults and adolescents \>15 years)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Department of Paediatrics

Falun, Region Dalarna, Sweden

RECRUITING

Department of Paediatrics, Eksjö Hospital

Eksjö, Region Jönköping County, 575 81, Sweden

RECRUITING

Department of Infectious Diseases, County Hospital Ryhov

Jönköping, Region Jönköping County, 55185, Sweden

RECRUITING

Department of Paediatrics

Jönköping, Region Jönköping County, 55185, Sweden

RECRUITING

Department of Infectious Diseases, Kalmar County Hospital

Kalmar, Region Kalmar County, 392 56, Sweden

RECRUITING

Department of Infectious Diseases

Uppsala, Region Uppsala, Sweden

NOT YET RECRUITING

Department of Paediatrics

Uppsala, Region Uppsala, Sweden

NOT YET RECRUITING

Department of Paediatrics

Örebro, Region Örebro County, Sweden

NOT YET RECRUITING

Department of Infectious Diseases, Linköping University Hospital

Linköping, Region Östergötland, 581 85, Sweden

RECRUITING

Department of Infectious Diseases, Vrinnevi Hospital

Norrköping, Region Östergötland, 603 79, Sweden

RECRUITING

Department of Paediatrics, Vrinnevi Hospital

Norrköping, Region Östergötland, 603 79, Sweden

RECRUITING

Department of Paediatrics

Skövde, Västra Götalandsregionen, Sweden

NOT YET RECRUITING

Related Publications (9)

  • Henningsson AJ, Asgeirsson H, Hammas B, Karlsson E, Parke A, Hoornstra D, Wilhelmsson P, Hovius JW. Two Cases of Borrelia miyamotoi Meningitis, Sweden, 2018. Emerg Infect Dis. 2019 Oct;25(10):1965-1968. doi: 10.3201/eid2510.190416.

    PMID: 31538916BACKGROUND
  • Uhnoo I, Cars O, Christensson D, Nystrom-Rosander C. First documented case of human babesiosis in Sweden. Scand J Infect Dis. 1992;24(4):541-7. doi: 10.3109/00365549209052642.

    PMID: 1411322BACKGROUND
  • Eimer J, Fernstrom L, Rohlen L, Grankvist A, Loo K, Nyman E, Henningsson AJ, Haglund M, Hultqvist V, Sjowall J, Wenneras C, Schon T. Spiroplasma ixodetis Infections in Immunocompetent and Immunosuppressed Patients after Tick Exposure, Sweden. Emerg Infect Dis. 2022 Aug;28(8):1681-1685. doi: 10.3201/eid2808.212524.

    PMID: 35876734BACKGROUND
  • Bjoersdorff A, Berglund J, Kristiansen BE, Soderstrom C, Eliasson I. [Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented]. Lakartidningen. 1999 Sep 29;96(39):4200-4. Swedish.

    PMID: 10544585BACKGROUND
  • Nilsson K, Elfving K, Pahlson C. Rickettsia helvetica in patient with meningitis, Sweden, 2006. Emerg Infect Dis. 2010 Mar;16(3):490-2. doi: 10.3201/eid1603.090184.

    PMID: 20202426BACKGROUND
  • Nilsson K, Lindquist O, Pahlson C. Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet. 1999 Oct 2;354(9185):1169-73. doi: 10.1016/S0140-6736(99)04093-3.

    PMID: 10513711BACKGROUND
  • Wenneras C, Wass L, Bergstrom B, Grankvist A, Lingblom C. Ten years of detecting Neoehrlichia mikurensis infections in Sweden: demographic, clinical and inflammatory parameters. Eur J Clin Microbiol Infect Dis. 2024 Nov;43(11):2083-2092. doi: 10.1007/s10096-024-04909-5. Epub 2024 Aug 13.

    PMID: 39136831BACKGROUND
  • Quarsten H, Henningsson A, Krogfelt KA, Strube C, Wenneras C, Mavin S. Tick-borne diseases under the radar in the North Sea Region. Ticks Tick Borne Dis. 2023 Jul;14(4):102185. doi: 10.1016/j.ttbdis.2023.102185. Epub 2023 Apr 26.

    PMID: 37116420BACKGROUND
  • Henningsson AJ, Aase A, Bavelaar H, Flottorp S, Forsberg P, Kirkehei I, Lovmar M, Nilsson K, Nyman D, Ornstein K, Sjowall J, Skogman BH, Tjernberg I, Aaberge I. Laboratory Methods for Detection of Infectious Agents and Serological Response in Humans With Tick-Borne Infections: A Systematic Review of Evaluations Based on Clinical Patient Samples. Front Public Health. 2021 Sep 20;9:580102. doi: 10.3389/fpubh.2021.580102. eCollection 2021.

    PMID: 34616701BACKGROUND

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, skin biopsies, cerebrospinal fluid, synovial fluid

MeSH Terms

Conditions

Tick-Borne Diseases

Condition Hierarchy (Ancestors)

Vector Borne DiseasesInfections

Central Study Contacts

Anna J Henningsson, Senior Associate Professor

CONTACT

Johanna Sjöwall, Associate Professor (docent)

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant, Senior Associate Professor

Study Record Dates

First Submitted

January 8, 2025

First Posted

January 17, 2025

Study Start

September 1, 2023

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2035

Last Updated

March 5, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication can be shared after anonymization, upon request

Locations